Quality Solutions That Reduce Compliance Risks in Clinical Trials

Choose from specialized solutions that help you increase quality and efficiency.

Get in Touch
Person on computer running quality assurance check

Why QA Teams Love TransPerfect

Our knowledge and experience in Quality Management is evidenced by our ability to create and curate strategic solutions to improve day-to-day operations / reducing administrative burdens. We have 30+ years of experience customizing these solutions. Here are some of your options:

    QMS Powered by Trial Interactive

    Our suite of eClinical solutions—part of TransPerfect’s Trial Interactive™ offering—improves visibility, reduces timelines, enhances quality, and mitigates risk. Explore our solutions for quality management, training management, audit management, vendor oversight, quality documents, and more.

    Learn More

    Training and Development

    We offer training support across any platform, in 200+ languages, and any subject matter. Our team centralizes your global learning requirements and manages the administrative work, so you can roll out your content quickly and cost-effectively.

    Learn More

    Language/Translation Solutions

    Ensure conceptual equivalence and cultural appropriateness in any language, minimizing time-to-market, mitigating risk, and ensuring compliance in global studies.

    Learn More

    Your Partner in Risk Mitigation

    Ensuring quality from R&D through commercialization is complex due to ever-evolving regulations, international policy, and corporate change, among many other variables. QA teams need all the support they can get to embed quality in the organizational culture through efficiencies such as digital and automated work streams, real-time oversight, e-learning, and translated quality documentation for multilingual operations.

    Improved Outcomes by the Numbers

    85% of clinical trials experience delays. Mitigating compliance risks by streamlining QA operations is a key strategy for preventing costly delays caused by CAPAs and inspection findings.

    1.2 M

    Saved by CRAs using our CTMS for day-to-day operations


    7.5 k

    Studies managed in Trial Interactive

    100 +

    TMFs rescued mid-study

    3 k

    eTMF study migrations completed

    50 %

    Faster site activation

    News and Thought Leadership

    Industry insights from our experts. We have the experience and solutions you need to navigate life sciences complexity and bring breakthroughs from lab to launch.

    C3 Summit 2025 - London

    Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to commercialization. The event offers sponsors, CROs, and biotech professionals opportunities to share knowledge, gain industry insights, and network. Please fill out the form to access the session ...

    C3 Summit 2025 - London

    From Reactive to Strategic: How AI Is Transforming Medical Information Contact Centers

    IntroductionFor decades, Medical Information (MI) has been an essential function within pharma, but largely a reactive one. This is especially true in medical information contact centers, which serve as the first line of support for HCPs and patients. When someone has a...

    Is AI Ready to Transform COA Development?

    AI is reshaping clinical development, but its greatest value may lie not in replacing human expertise, but rather in augmenting it. Across the drug development pipeline, AI is helping teams analyze vast datasets faster, identify promising compounds earlier, and uncover...

    Five Domains the FDA Wants You to Measure in PROs for Cancer—and Why Translation Affects All of Them

    In a recent "LifeSci Talks" episode, TransPerfect Global Practice Leader Mark Wade and Signant Health VP and eCOA Scientist Bill Byrom PhD discussed how new FDA guidance is reshaping how sponsors approach patient-reported outcomes (PROs) in cancer clinical trials. PROs...

    AI in Medical Information: Challenges, Opportunities, and the Path to Compliant Content at Scale

    Medical information teams are being asked to do more with less; faster turnaround, broader content demands, and zero tolerance for inaccuracy. AI offers a way forward, but adoption comes with real challenges: how do you validate accuracy, integrate literature review, and build ...

    Xtalks | Improve Recruitment Outcomes Through More Diverse Clinical Trials

    Since the advent of artificial intelligence (AI), medical device manufacturers have been early adopters for product enhancements. Now, manufacturers are evaluating their regulated content and other production processes for suitable applications of AI and automation technology. ...

    Potential Impact of the EU Biotech Act Proposal on Clinical Trial Activities

    The European Commission’s proposed Biotech Act introduces changes that could reshape how clinical trials are approved and managed across the EU. While the broader package spans multiple areas of the health ecosystem, proposed updates to the EU Clinical Trial Regulation (EU...

    Trusted by Life Sciences Organizations Big and Small

    Working in QA? Let’s connect.